CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $26,322 (100.0% shares, 0.0% debt)

Holdings (9)

SVRA SAVARA INC 47.6%

Value ($000) $12,525 Shares 3,313,602 Est. Cost $1.66 Unrealized +114.2%

XERS XERIS BIOPHARMA HOLDINGS INC 39.9%

Value ($000) $10,494 Shares 5,641,920 Est. Cost $2.16 Unrealized +6.1%

RZLT REZOLUTE INC 6.6%

Value ($000) $1,741 Shares 1,318,967 Est. Cost $9.52 Unrealized -82.9%

— MOLECULAR TEMPLATES INC 3.3%

Value ($000) $865 Shares 136,866 Est. Cost $6.32 Unrealized —

APGE APOGEE THERAPEUTICS INC 1.0%

Value ($000) $266 Shares 12,472 Est. Cost $22.03 Unrealized 0.0%

CMPX COMPASS THERAPEUTICS INC 0.6%

Value ($000) $171 Shares 86,773 Est. Cost $3.23 Unrealized -23.5%

ACRS ACLARIS THERAPEUTICS INC 0.5%

Value ($000) $133 Shares 19,473 Est. Cost $8.55 Unrealized 0.0%

— ALLAKOS INC 0.4%

Value ($000) $112 Shares 49,329 Est. Cost $3.36 Unrealized —

— ELEVATION ONCOLOGY INC 0.1%

Value ($000) $14 Shares 21,813 Est. Cost $9.95 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SVRA	SAVARA INC	3,313,602	$12,525	47.6%	$1.66	+114.2%	COM	805111101
XERS	XERIS BIOPHARMA HOLDINGS INC	5,641,920	$10,494	39.9%	$2.16	+6.1%	COM	98422E103
RZLT	REZOLUTE INC	1,318,967	$1,741	6.6%	$9.52	-82.9%	COM NEW	76200L309
—	MOLECULAR TEMPLATES INC	136,866	$865	3.3%	$6.32	—	COM NEW	608550208
APGE	APOGEE THERAPEUTICS INC	12,472	$266	1.0%	$22.03	0.0%	COM	03770N101
CMPX	COMPASS THERAPEUTICS INC	86,773	$171	0.6%	$3.23	-23.5%	COM	20454B104
ACRS	ACLARIS THERAPEUTICS INC	19,473	$133	0.5%	$8.55	0.0%	COM	00461U105
—	ALLAKOS INC	49,329	$112	0.4%	$3.36	—	COM	01671P100
—	ELEVATION ONCOLOGY INC	21,813	$14	0.1%	$9.95	—	COM	28623U101